News & Updates

Show Multimedia Only

Antiobesity drugs plus behavioural treatment induces more weight loss than medication alone

Oral antiobesity medications (AOMs) combined with behavioural treatment via telemedicine induces greater weight loss than medications alone, a study has shown.

Antiobesity drugs plus behavioural treatment induces more weight loss than medication alone

Just Now

Clozapine shows promise as second-line antipsychotic therapy

a day ago

In patients with first-episode psychosis who did not respond to initial antipsychotic treatment, the use of clozapine appears to improve clinical outcomes better than olanzapine and amisulpride, according to a study.

Clozapine shows promise as second-line antipsychotic therapy

a day ago

Healthcare environments remain unsafe for trans, gender-diverse people

25 Mar 2026 by

Transgender and gender-diverse (TGD) individuals are at the receiving end of inequities in psychological well-being and quality of life (QoL), driven in part by minority stress and discrimination, reveals a study.

Healthcare environments remain unsafe for trans, gender-diverse people

25 Mar 2026

Academic pressure contributes to depression in teens

25 Mar 2026

Academic pressure may be putting adolescents at risk of depressive symptoms and, possibly, self-harm, according to new research.

Academic pressure contributes to depression in teens

25 Mar 2026

Depression not a risk factor for mortality in CVD, study says

22 Mar 2026

Recent research indicates that depression does not contribute to increased mortality in patients with cardiovascular disease (CVD), and that the observed association is largely attributable to coexisting risk factors and comorbidities.

Depression not a risk factor for mortality in CVD, study says

22 Mar 2026

RT-based attention bias modification helps prevent PTSD in soldiers

21 Mar 2026 by

The use of response time (RT)-based attention bias modification (ABM) can protect soldiers against the development of post-traumatic stress disorder (PTSD) when implemented before exposure to combat, suggests a study.

RT-based attention bias modification helps prevent PTSD in soldiers

21 Mar 2026

Improving breast cancer survivorship as part of care continuum can reduce recurrence risk

21 Mar 2026 by

Journeying with breast cancer (BC) survivors through holistic multidisciplinary care enables them to cope better with physical and emotional stress, improves survivorship and adherence to endocrine therapy, and reduces recurrence risk, emphasized BC coach, Ms Isabel Galiano, and a multidisciplinary oncology care panel at the 14^th Asia-Pacific Breast Cancer Summit (APBCS 2026).

Improving breast cancer survivorship as part of care continuum can reduce recurrence risk

21 Mar 2026

Xanomeline-trospium chloride combo safe, effective in schizophrenia

20 Mar 2026

Treatment with xanomeline and trospium chloride (X/T) over 52 weeks appears safe and well tolerated, demonstrating durable symptom improvements in individuals with schizophrenia, reports a study.

Xanomeline-trospium chloride combo safe, effective in schizophrenia

20 Mar 2026

AI-assisted app shows promise in managing anorexia nervosa

19 Mar 2026 by

An artificial intelligence (AI)-assisted dietary recording application (app) demonstrates its potential as an alternative to expert evaluation for nutritional management in young patients with anorexia nervosa (AN), according to a study.

AI-assisted app shows promise in managing anorexia nervosa

19 Mar 2026

Original New Drug Application Approvals by US FDA (16-28 February 2026)

19 Mar 2026

New drug applications approved by US FDA as of 16-28 February 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-28 February 2026)

19 Mar 2026

News & Updates

Showing Psychiatry articles

Showing

Specialty:

Antiobesity drugs plus behavioural treatment induces more weight loss than medication alone

Antiobesity drugs plus behavioural treatment induces more weight loss than medication alone

Clozapine shows promise as second-line antipsychotic therapy

Clozapine shows promise as second-line antipsychotic therapy

Healthcare environments remain unsafe for trans, gender-diverse people

Healthcare environments remain unsafe for trans, gender-diverse people

Academic pressure contributes to depression in teens

Academic pressure contributes to depression in teens

Depression not a risk factor for mortality in CVD, study says

Depression not a risk factor for mortality in CVD, study says

RT-based attention bias modification helps prevent PTSD in soldiers

RT-based attention bias modification helps prevent PTSD in soldiers

Improving breast cancer survivorship as part of care continuum can reduce recurrence risk

Improving breast cancer survivorship as part of care continuum can reduce recurrence risk

Xanomeline-trospium chloride combo safe, effective in schizophrenia

Xanomeline-trospium chloride combo safe, effective in schizophrenia

AI-assisted app shows promise in managing anorexia nervosa

AI-assisted app shows promise in managing anorexia nervosa

Original New Drug Application Approvals by US FDA (16-28 February 2026)

Original New Drug Application Approvals by US FDA (16-28 February 2026)